Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-064961
Filing Date
2020-12-23
Accepted
2020-12-23 09:12:12
Documents
1
Period of Report
2020-12-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7869
  Complete submission text file 0001209191-20-064961.txt   9214
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 EVERTRUST PLAZA, 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address
Tinmouth Brian Philippe (Reporting) CIK: 0001797160 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 201409917